The intensive care unit (ICU) community needs to prepare for the challenges associated with the coronavirus disease 2019 (COVID-19) pandemic.
Patients with inflammatory bowel disease (IBD) who tested positive for SARS-CoV-2 had a good overall prognosis, despite IBD maintenance treatment.
The World Scleroderma Foundation developed preliminary guidance based on clinical questions on the SARS-CoV-2 infection for systemic sclerosis management during COVID-19.
Tests of multiple commonly used disinfection schemes on media with particle filtration efficiency of 95% found that heat was the most promising, nondestructive method for the preservation of filtration properties in meltblown fabrics, as well as N95-grade respirators.
As people around the world face prolonged periods of confinement to their homes during the COVID-19 pandemic, stress levels may disrupt sleep patterns and worsen overall mental health.
In patients hospitalized with coronavirus disease 2019 in the New York City area, the most common comorbidities were hypertension, obesity, and diabetes.
A new pooling method for SARS-CoV-2 diagnostic testing that uses standard protocols, reagents and equipment can be applied immediately in current clinical testing laboratories.
Researchers showed that the management of symptoms in patients with COVID-19 pneumonia with upper GI bleeding was possible without endoscopy.
Patients with psychiatric disorders are another population that may be more exposed to COVID-19, and the secondary effects of the pandemic may detract from ongoing treatment, thus worsening overall mental health.
Patients with COVID-19 pneumonia may present with 2 distinct phenotypes, each warranting distinct treatments.